Vancomycin-resistant Staphylococcus aureus primary prevention

Jump to navigation Jump to search

Vancomycin-resistant Staphylococcus aureus Microchapters

Home

Patient Information

Overview

Historical Perspective

Classification

Pathophysiology

Causes

Epidemiology and Demographics

Risk Factors

Screening

Natural History, Complications and Prognosis

Diagnosis

History and Symptoms

Physical Examination

Laboratory Findings

Chest X Ray

CT

MRI

Echocardiography or Ultrasound

Other Imaging Findings

Other Diagnostic Studies

Treatment

Medical Therapy

Surgery

Primary Prevention

Secondary Prevention

Cost-Effectiveness of Therapy

Future or Investigational Therapies

Case Studies

Case #1

Vancomycin-resistant Staphylococcus aureus primary prevention On the Web

Most recent articles

Most cited articles

Review articles

CME Programs

Powerpoint slides

Images

American Roentgen Ray Society Images of Vancomycin-resistant Staphylococcus aureus primary prevention

All Images
X-rays
Echo & Ultrasound
CT Images
MRI

Ongoing Trials at Clinical Trials.gov

US National Guidelines Clearinghouse

NICE Guidance

FDA on Vancomycin-resistant Staphylococcus aureus primary prevention

CDC on Vancomycin-resistant Staphylococcus aureus primary prevention

Vancomycin-resistant Staphylococcus aureus primary prevention in the news

Blogs on Vancomycin-resistant Staphylococcus aureus primary prevention

Directions to Hospitals Treating Vancomycin-resistant Staphylococcus aureus

Risk calculators and risk factors for Vancomycin-resistant Staphylococcus aureus primary prevention

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]

Please help WikiDoc by adding more content here. It's easy! Click here to learn about editing.

Overview

Use of appropriate infection control practices (such as wearing gloves before and after contact with infectious body substances and adherence to hand hygiene) by healthcare personnel can reduce the spread of VISA and VRSA. Because VISA and VRSA are only part of the larger problem of antimicrobial resistance in healthcare settings, CDC has started a campaign to prevent antimicrobial resistance. The campaign centers around four strategies that clinicians can use to prevent antimicrobial resistance, which include prevention of infections, effective diagnosis and treatment of infections, wise use of antimicrobials, and prevention of transmission. A series of evidence-based steps are described that can reduce the development and spread of resistant organisms such as VISA and VRSA.

References

Template:WH Template:WS